Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences.

× No keyword cloud information.

9 in total

1. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.

Authors: Gaurav Nayyar; David W Garber; Mayakonda N Palgunachari; Candyce E Monroe; Tamara D Keenum; Shaila P Handattu; Vinod K Mishra; G M Anantharamaiah
Journal: Atherosclerosis Date: 2012-06-23 Impact factor: 5.162

2. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

Authors: Gaurav Nayyar; Shaila P Handattu; Candyce E Monroe; Manjula Chaddha; Geeta Datta; Vinod K Mishra; Tamara D Keenum; Mayakonda N Palgunachari; David W Garber; G M Anantharamaiah
Journal: Atherosclerosis Date: 2010-10-27 Impact factor: 5.162

3. Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors: David A Elliott; Glenda M Halliday; Brett Garner
Journal: BMC Neurosci Date: 2010-02-20 Impact factor: 3.288

Review 4. Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors: Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal: J Mol Neurosci Date: 2004 Impact factor: 3.444

5. IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.

Authors: A C Zarpelon; T M Cunha; J C Alves-Filho; L G Pinto; S H Ferreira; I B McInnes; D Xu; F Y Liew; F Q Cunha; W A Verri
Journal: Br J Pharmacol Date: 2013-05 Impact factor: 8.739

6. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Authors: W J Strittmatter; A M Saunders; M Goedert; K H Weisgraber; L M Dong; R Jakes; D Y Huang; M Pericak-Vance; D Schmechel; A D Roses
Journal: Proc Natl Acad Sci U S A Date: 1994-11-08 Impact factor: 11.205

Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences.

1. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.

2. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

3. Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Review 4. Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

5. IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.

6. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

7. In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology.

8. The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture.

Review 9. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.